ITRI · XBRL financial data
Itron financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (ITRI's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 577* | 603 | 609 | 615 | 613* | 607 | 607 | 582 | 572* | 587 | 563 | 599 |
| Cost of goods and services sold | 381* | 398 | 399 | 406 | 399* | 390 | 383 | 362 | 340* | 351 | 332 | 354 |
| Gross profit | 196* | 205 | 210 | 210 | 214* | 217 | 224 | 220 | 232* | 236 | 231 | 245 |
| Research and development | 54* | 52 | 53 | 51 | 58* | 50 | 54 | 50 | 53* | 55 | 56 | 57 |
| Selling, general and administrative | 82* | 86 | 88 | 80 | 85* | 87 | 88 | 83 | 95* | 105 | 90 | 84 |
| Total operating expenses | 147* | 143 | 146 | 136 | 151* | 141 | 147 | 138 | 153* | 169 | 155 | 149 |
| Operating income (loss) | 49* | 63 | 65 | 74 | 63* | 76 | 76 | 82 | 79* | 68 | 76 | 95 |
| Interest income | year only | — | — | — | year only | — | — | — | year only | — | — | — |
| Interest expense | 2* | 2 | 2 | 6 | 6* | 6 | 6 | 6 | 6* | 6 | 6 | 6 |
| Other income (expense) | (1)* | 0 | (0) | 1 | 1* | (0) | 0 | 1 | 2* | (0) | 4 | 0 |
| Income tax expense (benefit) | 5* | 13 | 15 | 4 | 11* | 17 | 15 | 24 | (17)* | 14 | 27 | 26 |
| Net income (loss) | 44* | 52 | 51 | 78 | 58* | 65 | 68 | 66 | 102* | 53 | 53 | 71 |
| Earnings per share, basic USD per share | 0.98* | 1.13 | 1.12 | 1.73 | 1.29* | 1.44 | 1.50 | 1.43 | 2.25* | 1.20 | 1.21 | 1.63 |
| Earnings per share, diluted USD per share | 0.96* | 1.12 | 1.10 | 1.70 | 1.26* | 1.42 | 1.47 | 1.41 | 2.21* | 1.18 | 1.19 | 1.61 |
| Weighted average shares, basic millions of shares | 46* | 46 | 46 | 45 | 45* | 45 | 46 | 46 | 45* | 45 | 44 | 44 |
| Weighted average shares, diluted millions of shares | 46* | 46 | 47 | 46 | 46* | 46 | 46 | 47 | 46* | 45 | 45 | 44 |
Balance sheet
CSVFiscal quarters (ITRI's year ends in late December)
Cash flows
CSVFiscal quarters (ITRI's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 44* | 52 | 51 | 78 | 58* | 65 | 68 | 66 | 102* | 53 | 53 | 71 |
| Stock-based compensation | 8* | 11 | 10* | 10* | 12* | 17 | 17* | 14* | 15* | 20 | 12* | 12* |
| Depreciation and amortization | 14* | 13 | 14 | 15 | 15* | 12 | 12 | 12 | 13* | 19 | 19 | 18 |
| Net cash from operating activities | 48* | 41 | 52* | 65* | 80* | 72 | 97* | 118* | 119* | 86 | 88* | 102* |
| Purchases of property and equipment | 9* | 7 | 7* | 7* | 10* | 5 | 6* | 4* | 8* | 7 | 7* | 6* |
| Net cash from investing activities | (4)* | (41) | (7)* | (7)* | (9)* | (5) | (6)* | (6)* | (333)* | (522) | (4)* | (6)* |
| Proceeds from issuing common stock | 1* | 2 | 1* | 1* | 4* | 2 | 3* | 1* | 1* | 1 | 1* | 1* |
| Share repurchases | 0* | — | — | 0* | 0* | 0 | 0* | 0* | 100* | 100 | 52* | 0* |
| Repayments of long-term debt | year only | — | — | — | — | 0 | 0* | 0* | — | 460 | 0* | 0* |
| Net cash from financing activities | (1)* | 1 | 576* | (1)* | 3* | 2 | 3* | (3)* | (99)* | 131 | (52)* | (1)* |
| Net change in cash | 47* | (1) | 620* | 62* | 69* | 72 | 101* | 108* | (312)* | (308) | 32* | 95* |
Compare with peers
SIC 3825 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3825 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Itron | 840 | 599 | 102* | 43.9M | — | 10-QSep 30, 2026 |
| Bio-Rad Laboratories | 517 | 651 | 99* | not reported | — | 10-QJun 30, 2026 |
| Vontier | 266 | 757 | 116* | 135.2M | — | 10-QJul 3, 2026 |
| MKS | 454 | 1,248 | 243* | 67.6M | — | 10-QJun 30, 2026 |
| Cognex | 303 | 291 | 69* | 168.2M | — | 10-QJul 5, 2026 |
| Badger Meter | 68 | 236 | 43* | 28.6M | — | 10-QSep 30, 2026 |
| Mirion Technologies | 409 | 278 | 59* | not reported | — | 10-QSep 30, 2026 |
| Sensata Technologies Holding | 553 | 1,004 | 225* | 145.6M | — | 10-QSep 30, 2026 |
| Bruker | 185 | 839 | (77)* | 152.4M | 2.4 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.